Acremonium spp. cause human superficial infections including mycetoma, onychomycosis and keratitis. There are a few reports of systemic involvement in immunocompromised patients. However, isolated pulmonary infection in otherwise healthy hosts has never been reported in the literature.
INTRODUCTION
Acremonium formerly known as cephalosporium, is recognized as a causative agent of human skin infections (1) . Eumycotic mycetoma-mycetoma due to fungi-is caused by a variety of fungi but not commonly by Acremonium (2) . Moreover, the most common pathogens of onychomycosis (fungal infection of nails) are dermatophytes and Fusarium spp. followed by Acremonium
spp. (3).
Several cases of ocular infections particularly keratitis have been published in the literature (4) .
Localized infections (other than skin, nail and eyes) and systemic involvement due to Acremonium spp. are not common and have been reported in case reports.
Pneumonia and disseminated infections including meningitis, endocarditis, and cerebritis have been rarely reported. The reports of systemic infections, particularly pulmonary diseases, are almost always in patients with underlying risk factors such as malignancies and transplantation (1) . Literature reviews revealed no case of pulmonary disease in otherwise healthy patients.
We report an unusual case of pulmonary infection due to Acremonium in a diabetic man who was properly treated with itraconazole.
CASE SUMMARIES
A 59 year-old man was admitted with complaints of productive cough and dyspnea. He was healthy until approximately 2 months earlier when he experienced fever, chills and productive cough during a trip to the north of Iran. Non-massive hemoptysis occurred soon after Pulmonary infection due to Acremonium spp. has only been reported in 10 cases summarized in Table 1 . Physicians should be aware of rare fungal pathogens in patients with non-resolving pneumonia.
TANAFFOS
To our knowledge, this case is the first pulmonary infection caused by Acremonium in a patient without significant immunodeficiency except for well-controlled diabetes. Interestingly, in contrast to previous reports, our case was successfully treated with itraconazole and his follow-up revealed complete remission without respiratory or systemic complications.
